336 related articles for article (PubMed ID: 26689478)
1. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
Madak-Erdogan Z; Gong P; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
[TBL] [Abstract][Full Text] [Related]
2. Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination.
Berrodin TJ; Chang KC; Komm BS; Freedman LP; Nagpal S
Mol Endocrinol; 2009 Jan; 23(1):74-85. PubMed ID: 19036900
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens.
Chang KC; Wang Y; Bodine PV; Nagpal S; Komm BS
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):117-24. PubMed ID: 19914376
[TBL] [Abstract][Full Text] [Related]
4. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
5. The antagonist properties of Bazedoxifene after acute treatment are shifted to stimulatory action after chronic exposure in the liver but not in the uterus.
Buscato M; Fontaine C; Fabre A; Vinel A; Valera MC; Noirrit E; Guillaume M; Payrastre B; Métivier R; Arnal JF
Mol Cell Endocrinol; 2018 Sep; 472():87-96. PubMed ID: 29183806
[TBL] [Abstract][Full Text] [Related]
6. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
Messier TL; Boyd JR; Gordon JAR; Tye CE; Page NA; Toor RH; Zaidi SK; Komm BS; Frietze S; Stein JL; Lian JB; Stein GS
PLoS One; 2022; 17(7):e0271725. PubMed ID: 35862394
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
9. The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.
Han SJ; Begum K; Foulds CE; Hamilton RA; Bailey S; Malovannaya A; Chan D; Qin J; O'Malley BW
Mol Pharmacol; 2016 Jan; 89(1):14-26. PubMed ID: 26487511
[TBL] [Abstract][Full Text] [Related]
10. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
[TBL] [Abstract][Full Text] [Related]
11. A tissue-specific role of membrane-initiated ERα signaling for the effects of SERMs.
Gustafsson KL; Movérare-Skrtic S; Farman HH; Engdahl C; Henning P; Nilsson KH; Scheffler JM; Sehic E; Islander U; Levin E; Ohlsson C; Lagerquist MK
J Endocrinol; 2022 Mar; 253(2):75-84. PubMed ID: 35256537
[TBL] [Abstract][Full Text] [Related]
12. Preclinical breast effects of a tissue selective estrogen complex (TSEC) including conjugated estrogen with bazedoxifene.
Santen RJ; Song Y; Wang JP; Yue W
J Steroid Biochem Mol Biol; 2017 Jun; 170():61-64. PubMed ID: 27174719
[TBL] [Abstract][Full Text] [Related]
13. Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.
Song Y; Santen RJ; Wang JP; Yue W
Endocrinology; 2012 Dec; 153(12):5706-15. PubMed ID: 23070546
[TBL] [Abstract][Full Text] [Related]
14. Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.
Yue W; Wang J; Atkins KA; Bottalico L; Mesaros C; Blair IA; Santen RJ
Int J Cancer; 2018 Sep; 143(5):1259-1268. PubMed ID: 29577272
[TBL] [Abstract][Full Text] [Related]
15. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Pickar JH; Mirkin S
Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
[TBL] [Abstract][Full Text] [Related]
16. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
[TBL] [Abstract][Full Text] [Related]
17. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function.
Nordqvist J; Bernardi A; Islander U; Carlsten H
Immunobiology; 2017 Aug; 222(8-9):918-923. PubMed ID: 28551078
[TBL] [Abstract][Full Text] [Related]
18. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
Komm BS; Mirkin S; Jenkins SN
Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
[TBL] [Abstract][Full Text] [Related]
19. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
[TBL] [Abstract][Full Text] [Related]
20. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
Sheng S; Barnett DH; Katzenellenbogen BS
Mol Cell Endocrinol; 2008 Dec; 296(1-2):1-9. PubMed ID: 18951949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
